Search
for
Sort by
Research 31–60 of 1000+
- Differential Diagnosis of Female-Pattern Hair Loss
- Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial
- Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss.
- Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss
- Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: A Comparative, Clinical, and Trichoscopic Study
- A cross‐sectional study of hair parameters in the occipital region of male pattern hair loss
- Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women
- Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Efficacy and safety of a botanical shampoo containing <i>Morus alba</i> root extract in Republic of Korea: a single-center, open-label, pilot study in mild to moderate non-scarring alopecia of the scalp
- Role of low dose oral minoxidil in the treatment of hair loss: A review
- Systemic Lupus Erythematosus—Vasculopathy/Vasculitis, Susac Syndrome, and Myasthenia Gravis
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk
- Understanding polycystic ovary syndrome
- First case of V281+I172N/V281L CYP21A2 genotype associated with congenital adrenal hyperplasia form. A case report from South Italy
- Teriflunomida and hair disorders
- Antinuclear Antibody Positivity in Patients With Hair Loss After COVID-19 Infection
- The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- An Unusual Compulsive Behavior Related to Scalp Psoriasis and Hair Follicle Anxiety in Young Men
- Effect of a sphingolipid‐mimetic compound on the promotion of hair growth: A randomized, double‐blind, placebo‐controlled clinical trial
- Evaluation of the efficacy and safety of a dietary supplement on hair and skin aging in subjects with androgenic alopecia
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
- Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
- Diffuse hair loss associated with hyperprolactinaemia: report of three cases
- Patchy hair loss over the leg: a case of primary follicular mucinosis
- Usefulness of home‐use microneedle devices in the treatment of pattern hair loss
- Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair Loss: A Review of the Literature